Pulmonary Langerhans cell histiocytosis

R. Vassallo (Rochester, Ny, United States of America)

Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases
Session: PG5 - Interstitial lung diseases: selected orphan diseases
Session type: Postgraduate Course
Number: 27
Disease area: Interstitial lung diseases

Slide presentationPDF journal article, handout or slidesMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Vassallo (Rochester, Ny, United States of America). Pulmonary Langerhans cell histiocytosis. Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary Langerhans‘ cell histiocytosis
Source: Eur Respir J 2006; 28: Suppl. 50, 826s
Year: 2006

Pulmonary Langerhans' cell histiocytosis
Source: Eur Respir Mon; 2009: 46: 155–175
Year: 2009

Paediatric pulmonary Langerhans cell histiocytosis
Source: Breathe, 16 (2) 200003; 10.1183/20734735.0003-2020
Year: 2020



How I manage pulmonary Langerhans cell histiocytosis
Source: Eur Respir Rev, 26 (145) 170070; 10.1183/16000617.0070-2017
Year: 2017



Lung transplantation for pulmonary Langerhans‘ cell histiocytosis
Source: Eur Respir J 2005; 26: Suppl. 49, 635s
Year: 2005

Chemotherapy in patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018



Pneumothorax in patients with Langerhans cell histiocytosis
Source: International Congress 2017 – The acute patient: the clinical point-of-view
Year: 2017

Pneumothorax in pulmonary langerhans cell histiocytosis (PLCH)
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018




Pulmonary Langerhans' cell histiocytosis
Source: Respipedia Article
Year: 2016

Langerhans cell histiocytosis: is it an ILD?
Source: Virtual Congress 2021 – Interstitial lung diseases
Year: 2021


Genetic landscape of pulmonary langerhans cell histiocytosis
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018

Lung function progression in Langerhans cell histiocytosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Year: 2012


New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis
Source: Eur Respir Rev, 26 (145) 170042; 10.1183/16000617.0042-2017
Year: 2017



Pulmonary Langerhans cell histiocytosis associated with Hodgkin's lymphoma
Source: Eur Respir Rev 2009; 19: 86-88
Year: 2010


Effect of cladribine therapy on lung cysts in pulmonary Langerhans cell histiocytosis
Source: ERJ Open Res, 4 (1) 00089-2017; 10.1183/23120541.00089-2017
Year: 2018



Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012

Genetic landscape of adult Langerhans cell histiocytosis with lung involvement
Source: Eur Respir J, 55 (2) 1901190; 10.1183/13993003.01190-2019
Year: 2020



Pulmonary histiocytosis triggered by marijuana- and nicotine-abuse
Source: Eur Respir J 2002; 20: Suppl. 38, 338s
Year: 2002

Pulmonary Langerhans‘ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular involvement via exercise tests
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008


Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis
Source: Eur Respir J 2016; 47:1785-1796
Year: 2016